Narrow search
Showing 1,301 - 1,310 of 1,415
Cover Image
Cost-effectiveness, domestic favouritism and sustainability in public procurement : a comparative study of public preferences
Keulemans, Shelena; Walle, Steven van de - In: International journal of public sector management : IJPSM 30 (2017) 4, pp. 328-341
Persistent link: https://www.econbiz.de/10011724462
Cover Image
Economic modeling of risk-adapted screen-and-treat strategies in women at high risk for breast or ovarian cancer
Müller, Dirk; Danner, Marion C.; Schmutzler, Rita; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 5, pp. 739-750
Persistent link: https://www.econbiz.de/10012061271
Cover Image
A systematic review of pharmacoeconomic evaluations of erlotinib in the first-line treatment of advanced non-small cell lung cancer
Nguyen Cuc Thi Thu; Petrelli, Fabio; Scuri, Stefania; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 5, pp. 763-777
Persistent link: https://www.econbiz.de/10012061274
Cover Image
Stacking of abatement credits for cost-effective achievement of climate and water targets
Gren, Ing-Marie; Ang, Frederic - In: Ecological economics : the transdisciplinary journal of … 164 (2019), pp. 1-12
Persistent link: https://www.econbiz.de/10012193318
Cover Image
Does the use of health technology assessment have an impact on the utilisation of health care resources? : evidence from two European countries
Corbacho, Belen; Drummond, Michael F.; Santos, Rita; … - In: The European journal of health economics : HEPAC ; … 21 (2020) 4, pp. 621-634
Persistent link: https://www.econbiz.de/10012421914
Cover Image
Cost-(in)effective public good provision : an experimental exploration
Chan, Nathan W.; Knowles, Stephen Mark; Peeters, Ronald; … - 2021
Persistent link: https://www.econbiz.de/10012429886
Cover Image
A MEA is a MEA is a MEA? : sequential decision making and the impact of different managed entry agreements at the manufacturer and payer level, using a case study for an oncology drug in England
Buyukkaramikli, Nasuh C.; Wigfield, Peter; Men Thi Hoang - In: The European journal of health economics 22 (2021) 1, pp. 51-73
Persistent link: https://www.econbiz.de/10012433945
Cover Image
A comparison of published time invariant Markov models with Partitioned Survival models for cost effectiveness estimation : three case studies of treatments for glioblastoma multiforme
Connock, Martin; Auguste, Peter; Armoiry, Xavier - In: The European journal of health economics 22 (2021) 1, pp. 89-100
Persistent link: https://www.econbiz.de/10012433955
Cover Image
Stratified medicine in schizophrenia : how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life?
Jin, Huajie; McCrone, Paul; MacCabe, James H. - In: The European journal of health economics : HEPAC ; … 20 (2019) 9, pp. 1425-1435
Persistent link: https://www.econbiz.de/10012221385
Cover Image
Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease : results from the EVINCI study
Lorenzoni, Valentina; Bellelli, Stefania; Caselli, Chiara; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 9, pp. 1437-1449
Persistent link: https://www.econbiz.de/10012221398